Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · October 02, 2023

Interim Effectiveness of Influenza Vaccines in Preventing Influenza-Associated Hospitalizations During the 2023 Southern Hemisphere Influenza Season

MMWR. Morbidity and Mortality Weekly Report

 

Additional Info

Disclosure statements are available on the authors' profiles:

MMWR. Morbidity and Mortality Weekly Report
Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalizations - REVELAC-i Network, March-July 2023
MMWR Morb. Mortal. Wkly. Rep. 2023 Sep 15;72(37)1010-1015, AL Fowlkes, F Nogareda, A Regan, S Loayza, JM Mancio, LM Duca, P Couto, J Leite, A Rodriguez, D Salas, E Azziz-Baumgartner

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading